Go Pro

Marsh & McLennan Companies (NYSE:MRSH) Given New $197.00 Price Target at Mizuho

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Mizuho raised its price target on Marsh & McLennan Companies to $197 from $194 while keeping a neutral rating, implying about 10% upside from the current share price.
  • The broader analyst view remains mixed: the stock has an average Hold rating, with a consensus price target of $200.06 and a range of buy, hold, and sell opinions.
  • Marsh & McLennan recently beat quarterly EPS estimates, reporting $3.29 per share on $7.30 billion in revenue, though CEO John Q. Doyle also sold shares in a pre-arranged transaction.
  • MarketBeat previews the top five stocks to own by August 1st.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) had its target price upped by research analysts at Mizuho from $194.00 to $197.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has a "neutral" rating on the financial services provider's stock. Mizuho's price target would indicate a potential upside of 10.14% from the company's current price.

Other equities research analysts have also issued research reports about the stock. Weiss Ratings lowered shares of Marsh & McLennan Companies from a "hold (c)" rating to a "hold (c-)" rating in a report on Monday, May 11th. Keefe, Bruyette & Woods upped their target price on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a "market perform" rating in a research note on Friday, April 17th. JPMorgan Chase & Co. decreased their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating for the company in a research note on Thursday, April 9th. Piper Sandler lowered their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating for the company in a report on Tuesday, May 26th. Finally, Bank of America dropped their price objective on Marsh & McLennan Companies from $181.00 to $174.00 and set an "underperform" rating on the stock in a research note on Tuesday, April 14th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $200.06.

Check Out Our Latest Stock Report on Marsh & McLennan Companies

Marsh & McLennan Companies Price Performance

Shares of MRSH stock opened at $178.87 on Thursday. Marsh & McLennan Companies has a 52-week low of $156.60 and a 52-week high of $216.32. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. The company has a market cap of $86.41 billion, a P/E ratio of 22.36, a price-to-earnings-growth ratio of 2.59 and a beta of 0.61.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping analysts' consensus estimates of $3.21 by $0.08. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company's revenue for the quarter was up 7.6% compared to the same quarter last year. On average, equities analysts anticipate that Marsh & McLennan Companies will post 10.37 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares of the company's stock, valued at $18,889,506.81. The trade was a 12.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Marsh & McLennan Companies

Several institutional investors and hedge funds have recently bought and sold shares of the company. Procyon Advisors LLC grew its stake in shares of Marsh & McLennan Companies by 2.5% during the fourth quarter. Procyon Advisors LLC now owns 2,279 shares of the financial services provider's stock worth $423,000 after acquiring an additional 56 shares during the last quarter. PFG Investments LLC lifted its holdings in shares of Marsh & McLennan Companies by 3.3% in the 4th quarter. PFG Investments LLC now owns 1,758 shares of the financial services provider's stock valued at $326,000 after buying an additional 56 shares during the period. Lindenwold Advisors INC boosted its position in Marsh & McLennan Companies by 0.4% in the 3rd quarter. Lindenwold Advisors INC now owns 14,994 shares of the financial services provider's stock worth $3,022,000 after purchasing an additional 62 shares in the last quarter. SeaCrest Wealth Management LLC grew its position in Marsh & McLennan Companies by 3.9% during the fourth quarter. SeaCrest Wealth Management LLC now owns 1,673 shares of the financial services provider's stock valued at $306,000 after buying an additional 63 shares during the period. Finally, EP Wealth Advisors LLC increased its holdings in Marsh & McLennan Companies by 0.8% in the second quarter. EP Wealth Advisors LLC now owns 8,337 shares of the financial services provider's stock valued at $1,823,000 after buying an additional 69 shares in the last quarter. 87.99% of the stock is owned by hedge funds and other institutional investors.

About Marsh & McLennan Companies

(Get Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Further Reading

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines